Atlas Trials

Dyslipidemias

374 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Dyslipidemias

RecordFirmDate
Effects of an Indoor Cycling Program on Cardio-Metabolic Factors in Women With Obesity and Normal Body Weight (NCT04456192)Poznan University of Physical Education2013-01-01
Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial (NCT02730559)The Hospital for Sick Children2012-11-01
The Therapeutic Effects of Statins and Berberine on the Hyperlipemia (NCT01697735)Wenzhou Medical University2012-09-01
Complete Health Improvement Program (CHIP) Risk Reduction/Claims Evaluation Project (NCT02977884)Ohio University2012-08-01
Diet Intervention and GEnetic STudy (DIGEST-Pilot) (NCT01658137)McMaster University2012-07-01
Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL (NCT01450410)Xavier Pinto Sala2012-07-01
Cardiovascular Effects of Salvia Miltiorrhiza Extract (Danshen) (NCT01563770)Radboud University Medical Center2012-04-01
The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults (NCT01696097)Purdue University2012-04-01
Lifestyle Interventions and Metabolic Profile in Obese Children (NCT03728621)University of Milan2012-01-01
A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets (NCT01581372)University of Alberta2011-12-01
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia (NCT01435382)Pfizer2011-10-01
A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic (NCT01462877)Abbott2011-10-01
Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease (NCT01308203)Daniel A. Siniawski2011-10-01
Cholesterol-lowering Effects of Plant Stanol Ester (NCT02316808)Raisio Group2011-08-01
A Study of LY2484595 in Japanese Subjects (NCT01375075)Eli Lilly and Company2011-06-01
Retrospective Evaluation of Athens Complete Health Improvement Program (CHIP) Database (NCT03025451)Ohio University2011-05-01
TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care (NCT01418716)Fonds de la Recherche en Santé du Québec2011-04-01
Reducing Disparities in Late Life Depression and Metabolic Syndrome (NCT01428791)Rush University Medical Center2011-03-01
Lipid-lowering Effect of Plant Stanol Yogurt (NCT01882517)Raisio Group2011-03-01
Lipid Metabolic Status in Thyroid Carcinoma (NCT01487057)Prof. Dr. I. Chiricuta Institute of Oncology2011-02-01
Epidemiological Study on the Relationship Between Respiratory Health and Air Pollution From Industrial Sources (NCT02490553)University Hospital, Lille2011-01-01
Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis (NCT01250990)University of Pennsylvania2010-11-01
GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes (NCT01217112)Jazz Pharmaceuticals2010-10-01
Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204) (NCT01245738)Merck Sharp & Dohme LLC2010-08-01
Effects of a Bakery Product Enriched With Fibre and L-carnitine on Insulin Resistance in Patients With Metabolic Syndrome (NCT02281253)Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana2010-04-01
Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients (NCT00931320)AstraZeneca2009-07-01
Effects of Psyllium on Niacin Tolerability (NCT03370848)VA Greater Los Angeles Healthcare System2009-03-01
Get-a-Grip Lifestyle Management Programme (NCT04003259)Tampere University2009-01-01
Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial (NCT03221816)Casa de Saúde santa Marcelina2008-12-01
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects (NCT00707746)Kastle Therapeutics, LLC2008-10-01
Production of Free Fatty Acids From Blood Triglycerides (NCT00911482)Mayo Clinic2008-06-01
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia (NCT00694109)Kastle Therapeutics, LLC2008-04-01
Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood (NCT00639158)Abbott2008-02-01
Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study (NCT00540293)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2007-10-01
An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin (NCT00678743)Provident Clinical Research2007-08-01
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia (NCT00607373)Kastle Therapeutics, LLC2007-07-01
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia (NCT00477594)Kastle Therapeutics, LLC2007-05-01
Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia. (NCT00770653)Takeda2007-04-01
European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia (NCT00412698)Sanofi2006-12-01
Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome (NCT00362908)University of Washington2006-09-01
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration (NCT00362180)Kastle Therapeutics, LLC2006-07-01
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia (NCT00316095)Boehringer Ingelheim2006-04-01
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) (NCT00455403)Washington University School of Medicine2006-04-01
Lipid-lowering Effect of Plant Stanol Ester Yoghurt Drinks (NCT02628990)Raisio Group2005-06-01
Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects (NCT00192621)Kirby Institute2004-11-01
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) (NCT00455325)Washington University School of Medicine2004-09-01
A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol (NCT00645151)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2004-04-01
A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD) (NCT00644709)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2003-09-01
Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand (NCT00647543)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2003-08-01
A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol (NCT00644670)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2003-06-01
Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels (NCT00330980)University of California, San Diego2000-04-01
From Known to New Genes in Dyslipidemia (NCT03939039)Hospices Civils de Lyon2000-01-01
Exploring the Comorbidity Between Mental Disorders and General Medical Conditions (NCT03847753)University of Aarhus2000-01-01
← Previous Next →

Track Dyslipidemias automatically

Every clearance here is in the API, with alerts when new ones post.